107 related articles for article (PubMed ID: 29366431)
1. Prednisolone Effects on Urine Cross-Linked N-Telopeptides of Type I Collagen (Ntx) Diurnal Rhythms in Children.
Wolthers OD; Heuck C
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):158-161. PubMed ID: 29366431
[TBL] [Abstract][Full Text] [Related]
2. The timing of administration of exogenous glucocorticoid affects 24hour growth hormone secretion in children.
Wolthers OD; Ramshanker N; Heuck C; Frystyk J
Growth Horm IGF Res; 2017 Aug; 35():40-44. PubMed ID: 28688245
[TBL] [Abstract][Full Text] [Related]
3. Diurnal leptin rhythms in children treated with prednisolone once daily in the morning or in the evening.
Wolthers OD; Heuck C
J Pediatr Endocrinol Metab; 2002 Mar; 15(3):313-8. PubMed ID: 11924934
[TBL] [Abstract][Full Text] [Related]
4. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.
Gertz BJ; Clemens JD; Holland SD; Yuan W; Greenspan S
Calcif Tissue Int; 1998 Aug; 63(2):102-6. PubMed ID: 9685512
[TBL] [Abstract][Full Text] [Related]
5. Urinary N-telopeptides of type I collagen in healthy children.
Sato J; Hasegawa K; Tanaka H; Morishima T
Pediatr Int; 2010 Jun; 52(3):398-401. PubMed ID: 20113422
[TBL] [Abstract][Full Text] [Related]
6. Circadian variation in urinary excretion of bone collagen cross-links.
Bollen AM; Martin MD; Leroux BG; Eyre DR
J Bone Miner Res; 1995 Dec; 10(12):1885-90. PubMed ID: 8619368
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age.
Lapillonne A; Travers R; DiMaio M; Salle BL; Glorieux FH
Pediatrics; 2002 Jul; 110(1 Pt 1):105-9. PubMed ID: 12093954
[TBL] [Abstract][Full Text] [Related]
8. The effect of calcium supplementation on the circadian rhythm of bone resorption.
Blumsohn A; Herrington K; Hannon RA; Shao P; Eyre DR; Eastell R
J Clin Endocrinol Metab; 1994 Sep; 79(3):730-5. PubMed ID: 8077353
[TBL] [Abstract][Full Text] [Related]
9. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
Rosen HN; Dresner-Pollak R; Moses AC; Rosenblatt M; Zeind AJ; Clemens JD; Greenspan SL
Calcif Tissue Int; 1994 Jan; 54(1):26-9. PubMed ID: 8118749
[TBL] [Abstract][Full Text] [Related]
10. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
11. Relationship between melatonin and bone resorption rhythms in premenopausal women.
St Hilaire MA; Rahman SA; Gooley JJ; Witt-Enderby PA; Lockley SW
J Bone Miner Metab; 2019 Jan; 37(1):60-71. PubMed ID: 29318392
[TBL] [Abstract][Full Text] [Related]
12. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
[TBL] [Abstract][Full Text] [Related]
13. A prospective longitudinal study of urinary excretion of a bone resorption marker in adolescents.
Bollen AM
Ann Hum Biol; 2000; 27(2):199-211. PubMed ID: 10768424
[TBL] [Abstract][Full Text] [Related]
14. Comparison of analytical performance and biological variability of three bone resorption assays.
Ju HS; Leung S; Brown B; Stringer MA; Leigh S; Scherrer C; Shepard K; Jenkins D; Knudsen J; Cannon R
Clin Chem; 1997 Sep; 43(9):1570-6. PubMed ID: 9299935
[TBL] [Abstract][Full Text] [Related]
15. Determination of NTx in second-morning urine: a proposal for the standardization of morning urine collection.
Wendlová J; Mikulecký M
Wien Med Wochenschr; 2001; 151(18-20):472-5. PubMed ID: 11817260
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosis.
Chubb SA; Mandelt C; Vasikaran S
Clin Biochem; 2016 May; 49(7-8):529-33. PubMed ID: 26680567
[TBL] [Abstract][Full Text] [Related]
17. Bone turnover in neonates: changes of urinary excretion rate of collagen type I cross-linked peptides during the first days of life and influence of gestational age.
Mora S; Prinster C; Bellini A; Weber G; Proverbio MC; Puzzovio M; Bianchi C; Chiumello G
Bone; 1997 Jun; 20(6):563-6. PubMed ID: 9177872
[TBL] [Abstract][Full Text] [Related]
18. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption.
Clemens JD; Herrick MV; Singer FR; Eyre DR
Clin Chem; 1997 Nov; 43(11):2058-63. PubMed ID: 9365389
[TBL] [Abstract][Full Text] [Related]
19. [Normal urine levels of the aminoterminal telopeptide of type I collagen (NTx) in premature newborns in the first week of life].
Praticò G; Palano GM; Curreri R; Marletta M; Parisi G; Praticò ER
Pediatr Med Chir; 2005; 27(1-2):81-5. PubMed ID: 16922049
[TBL] [Abstract][Full Text] [Related]
20. Bone resorption varies as a function of time of day and quantity of dietary long chain polyunsaturated fatty acids.
Mollard RC; Weiler HA
J Nutr Biochem; 2008 Jul; 19(7):482-8. PubMed ID: 17904343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
